CED Life Science Conference 2018 - Showcase Only
Sub-sector: Biotech and Pharmaceutical
Year Founded: 2014
Ribometrix is a platform therapeutics company discovering novel small molecule drugs that target functional 3D RNA structures to treat human diseases. There is an enormous opportunity for small molecules drugs that target RNA, including therapeutically attractive targets across a wide range of indications. We are leveraging a unique technology and our deep RNA expertise for small molecule drug discovery against RNA targets.
Mike Solomon, CEO
Kevin Weeks, Founder
Katie Warner, Sr. Director of Research & Co-Founder
Christine Hajdin, Assoc. Director, Computational Sciences
Jackie Grant, Director of BD
KEY MILESTONES TO DATE
- Closed $7.5M seed round in Oct 2017
One NC Small Business Program
(main lab located in Durham, NC)
Past CED Life Science Conference selection: 2017 - Showcase
Learn more about the CED Life Science Conference.